A pharmacodynamic study of the FLT3 inhibitor KW-2449 yields insight into the basis for clinical response.
暂无分享,去创建一个
S. Akinaga | Y. Shiotsu | J. Cortes | J. Karp | M. Levis | K. Pratz | D. Small | G. Roboz | A. Stine | N. Rao | Omotayo A Arowojolu | Aiko Shudo | Omotayo A. Arowojolu